ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
2,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
3,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
4,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
5,5,Tension headache,Headaches NEC,Headaches,Nerv,N
6,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
7,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
8,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
9,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
10,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
10,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
11,1,Sinus arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
12,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
13,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
14,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
14,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
14,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
15,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
16,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
17,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
18,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
19,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
19,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
20,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
20,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
23,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
24,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
25,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
27,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
28,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
29,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
31,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
32,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
33,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
34,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
35,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
37,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
39,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
39,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
40,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
41,1,Central venous catheterisation,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
41,2,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
41,3,Vascular device occlusion,Vascular complications associated with device,Complications associated with device,Genrl,N
42,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Medical device site erosion,Complications associated with device NEC,Complications associated with device,Genrl,N
